Company Name: Progenics Pharmaceuticals Inc.    

Progenics Pharmaceuticals Inc. is engaged in the development of oncology medicines. The company’s developmental pipeline includes both diagnostic and therapeutic product candidates for prostate cancer and a treatment for pheochromocytoma and paraganglioma.

Ticker Symbol: PGNX (NASDAQ)

Company Website: www.progenics.com

Social Media:

Progenics Pharmaceuticals LinkedIn

Progenics Pharmaceuticals Twitter

Headquarters: Tarrytown, NY